Synapse Open Synapse
Biology

A synthetic lethal drug for microsatellite instability cancers

Nature Medicine ·

In a phase 1 trial, inhibition of the Werner syndrome helicase (WRN) enzyme exploits a new synthetic lethal vulnerability in cancers with microsatellite instability, offering a new way to target these tumors beyond immune checkpoint inhibition.

Latest from Nature Medicine